Background Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …

Importance Growing interest in microbial dysbiosis during critical illness has raised
questions about the therapeutic potential of microbiome modification with probiotics. Prior …

Importance Randomized clinical trials (RCTs) of therapeutic-dose heparin in patients hospitalized
with COVID-19 produced conflicting results, possibly due to heterogeneity of treatment …

Objectives: Critical illness can have a significant psychological impact on patients and their
families. To inform the design of a larger trial, we assessed feasibility of ICU diaries and …

Background Use of hydroxychloroquine in hospitalized patients with coronavirus disease
2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged
in December 2019 causing the coronavirus disease (COVID-19) pandemic. Currently, there …

Purpose Observational research focused upon emerging infectious diseases such as Ebola
virus, Middle East respiratory syndrome, and Zika virus has been challenging to quickly …

Background Platelet transfusions are commonly used to treat critically ill patients with
thrombocytopenia. Whether platelet transfusions are associated with a reduction in the risk of …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged
in December 2019 causing the coronavirus disease 2019 (COVID-19) pandemic. Currently, …

We thank authors Gobat, Butler, Webb and Nichol for their thoughtful and practical suggestions
to advance our ability to perform practiceinforming research in the context of outbreaks …